| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | hSH3 | 5.16e-06 | 3 | 25 | 2 | IPR029294 | |
| Domain | hSH3 | 5.16e-06 | 3 | 25 | 2 | PF14603 | |
| Domain | NTF2-like_dom | 1.79e-04 | 15 | 25 | 2 | IPR032710 | |
| Domain | EF-hand_1 | 1.75e-02 | 152 | 25 | 2 | PF00036 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 16831444 | ||
| Pubmed | 5.24e-05 | 971 | 25 | 6 | 33306668 | ||
| Pubmed | 1.06e-04 | 1103 | 25 | 6 | 34189442 | ||
| Pubmed | 1.31e-04 | 708 | 25 | 5 | 39231216 | ||
| Pubmed | 1.36e-04 | 24 | 25 | 2 | 25348719 | ||
| Pubmed | 3.98e-04 | 493 | 25 | 4 | 15368895 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 4.24e-04 | 1425 | 25 | 6 | 30948266 | |
| Pubmed | 4.40e-04 | 43 | 25 | 2 | 30733279 | ||
| Pubmed | 4.48e-04 | 1440 | 25 | 6 | 30833792 | ||
| Pubmed | 5.34e-04 | 533 | 25 | 4 | 25544563 | ||
| Pubmed | 5.97e-04 | 549 | 25 | 4 | 38280479 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 6.28e-04 | 235 | 25 | 3 | 28378594 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 9.02e-03 | 797 | 25 | 3 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 1.28e-02 | 316 | 25 | 2 | chr3p21 | |
| GeneFamily | EF-hand domain containing | 8.90e-03 | 219 | 12 | 2 | 863 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP | 1.15e-06 | 200 | 25 | 5 | M7613 | |
| Coexpression | GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN | 1.15e-06 | 200 | 25 | 5 | M7618 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 1.76e-06 | 218 | 25 | 5 | M1099 | |
| Coexpression | GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP | 2.55e-06 | 235 | 25 | 5 | MM978 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PLASMA_CELL_AGEING | 1.31e-05 | 6 | 25 | 2 | MM3842 | |
| Coexpression | GSE6269_FLU_VS_E_COLI_INF_PBMC_UP | 1.69e-05 | 164 | 25 | 4 | M5653 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 1.99e-05 | 171 | 25 | 4 | M5655 | |
| Coexpression | GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN | 3.60e-05 | 199 | 25 | 4 | M4738 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN | 3.67e-05 | 200 | 25 | 4 | M5068 | |
| Coexpression | GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP | 3.67e-05 | 200 | 25 | 4 | M6352 | |
| Coexpression | GSE17721_LPS_VS_CPG_2H_BMDC_UP | 3.67e-05 | 200 | 25 | 4 | M3989 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP | 3.67e-05 | 200 | 25 | 4 | M3913 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 3.67e-05 | 200 | 25 | 4 | M9598 | |
| Coexpression | CUI_DEVELOPING_HEART_C8_MACROPHAGE | 1.26e-04 | 275 | 25 | 4 | M39305 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 1.73e-04 | 567 | 25 | 5 | M1097 | |
| Coexpression | GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP | 2.54e-04 | 616 | 25 | 5 | MM977 | |
| Coexpression | RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS | 3.07e-04 | 347 | 25 | 4 | M41751 | |
| Coexpression | GSE13547_WT_VS_ZFX_KO_BCELL_UP | 4.91e-04 | 163 | 25 | 3 | M2997 | |
| Coexpression | GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN | 4.91e-04 | 163 | 25 | 3 | M5640 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 5.36e-04 | 168 | 25 | 3 | M7007 | |
| Coexpression | GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP | 5.55e-04 | 170 | 25 | 3 | M5657 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN | 7.55e-04 | 189 | 25 | 3 | M4261 | |
| Coexpression | GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP | 7.55e-04 | 189 | 25 | 3 | M4921 | |
| Coexpression | GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN | 7.78e-04 | 191 | 25 | 3 | M4715 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN | 7.90e-04 | 192 | 25 | 3 | M4277 | |
| Coexpression | GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN | 7.90e-04 | 192 | 25 | 3 | M4296 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN | 8.27e-04 | 195 | 25 | 3 | M4279 | |
| Coexpression | GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN | 8.27e-04 | 195 | 25 | 3 | M4917 | |
| Coexpression | EGFR_UP.V1_DN | 8.39e-04 | 196 | 25 | 3 | M2633 | |
| Coexpression | GSE2706_2H_VS_8H_LPS_STIM_DC_UP | 8.39e-04 | 196 | 25 | 3 | M4731 | |
| Coexpression | GSE2706_2H_VS_8H_R848_STIM_DC_DN | 8.39e-04 | 196 | 25 | 3 | M4730 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_DC_UP | 8.51e-04 | 197 | 25 | 3 | M4698 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN | 8.51e-04 | 197 | 25 | 3 | M7121 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_19_PRECICTIVE_ICB_RESPONSE | 8.51e-04 | 197 | 25 | 3 | MM17080 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN | 8.64e-04 | 198 | 25 | 3 | M4272 | |
| Coexpression | GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN | 8.64e-04 | 198 | 25 | 3 | M4264 | |
| Coexpression | GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN | 8.64e-04 | 198 | 25 | 3 | M8768 | |
| Coexpression | GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN | 8.77e-04 | 199 | 25 | 3 | M5065 | |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP | 8.77e-04 | 199 | 25 | 3 | M9452 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN | 8.77e-04 | 199 | 25 | 3 | M4635 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN | 8.77e-04 | 199 | 25 | 3 | M3775 | |
| Coexpression | GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN | 8.77e-04 | 199 | 25 | 3 | M3286 | |
| Coexpression | GSE3982_MAST_CELL_VS_NKCELL_UP | 8.77e-04 | 199 | 25 | 3 | M5450 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN | 8.77e-04 | 199 | 25 | 3 | M3669 | |
| Coexpression | GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP | 8.77e-04 | 199 | 25 | 3 | M4427 | |
| Coexpression | GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN | 8.89e-04 | 200 | 25 | 3 | M9055 | |
| Coexpression | GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP | 8.89e-04 | 200 | 25 | 3 | M8559 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 8.89e-04 | 200 | 25 | 3 | M8554 | |
| Coexpression | GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN | 8.89e-04 | 200 | 25 | 3 | M5059 | |
| Coexpression | GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP | 8.89e-04 | 200 | 25 | 3 | M8564 | |
| Coexpression | GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN | 8.89e-04 | 200 | 25 | 3 | M5094 | |
| Coexpression | GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN | 8.89e-04 | 200 | 25 | 3 | M6457 | |
| Coexpression | GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN | 8.89e-04 | 200 | 25 | 3 | M6475 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 8.89e-04 | 200 | 25 | 3 | M6477 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP | 8.89e-04 | 200 | 25 | 3 | M5131 | |
| Coexpression | GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN | 8.89e-04 | 200 | 25 | 3 | M9361 | |
| Coexpression | GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP | 8.89e-04 | 200 | 25 | 3 | M8053 | |
| Coexpression | GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP | 8.89e-04 | 200 | 25 | 3 | M8073 | |
| Coexpression | GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN | 8.89e-04 | 200 | 25 | 3 | M5806 | |
| Coexpression | GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP | 8.89e-04 | 200 | 25 | 3 | M5821 | |
| Coexpression | GSE2585_CTEC_VS_MTEC_THYMUS_DN | 8.89e-04 | 200 | 25 | 3 | M6274 | |
| Coexpression | GSE22886_CTRL_VS_LPS_24H_DC_DN | 8.89e-04 | 200 | 25 | 3 | M4520 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP | 8.89e-04 | 200 | 25 | 3 | M4545 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN | 8.89e-04 | 200 | 25 | 3 | M3973 | |
| Coexpression | GSE10325_MYELOID_VS_LUPUS_MYELOID_DN | 8.89e-04 | 200 | 25 | 3 | M3097 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 8.89e-04 | 200 | 25 | 3 | M6614 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN | 8.89e-04 | 200 | 25 | 3 | M6601 | |
| Coexpression | GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 8.89e-04 | 200 | 25 | 3 | M6625 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP | 8.89e-04 | 200 | 25 | 3 | M78 | |
| Coexpression | GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN | 8.89e-04 | 200 | 25 | 3 | M7336 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP | 8.89e-04 | 200 | 25 | 3 | M6004 | |
| Coexpression | HALLMARK_INTERFERON_GAMMA_RESPONSE | 8.89e-04 | 200 | 25 | 3 | M5913 | |
| Coexpression | GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN | 8.89e-04 | 200 | 25 | 3 | M9539 | |
| Coexpression | GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN | 8.89e-04 | 200 | 25 | 3 | M8208 | |
| Coexpression | GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN | 8.89e-04 | 200 | 25 | 3 | M9586 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 8.89e-04 | 200 | 25 | 3 | M9576 | |
| Coexpression | KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP | 8.89e-04 | 200 | 25 | 3 | M3014 | |
| Coexpression | GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP | 8.89e-04 | 200 | 25 | 3 | M7879 | |
| Coexpression | GSE36009_WT_VS_NLRP10_KO_DC_UP | 8.89e-04 | 200 | 25 | 3 | M8775 | |
| Coexpression | GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN | 8.89e-04 | 200 | 25 | 3 | M7814 | |
| Coexpression | GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN | 8.89e-04 | 200 | 25 | 3 | M6513 | |
| Coexpression | DAUER_STAT3_TARGETS_DN | 9.59e-04 | 48 | 25 | 2 | M13696 | |
| Coexpression | STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN | 1.08e-03 | 51 | 25 | 2 | M2102 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP | 1.16e-03 | 219 | 25 | 3 | M41142 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 1.19e-03 | 498 | 25 | 4 | M1741 | |
| Coexpression | ZHENG_BOUND_BY_FOXP3 | 1.27e-03 | 507 | 25 | 4 | MM1030 | |
| Coexpression | DOANE_RESPONSE_TO_ANDROGEN_DN | 1.54e-03 | 242 | 25 | 3 | M12816 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-06 | 170 | 25 | 4 | 46a81d505de845cc59f80594fce338f7fdb9250f | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-06 | 170 | 25 | 4 | 1a9a0487c35cf3fd5806d1f0f0e91ef0e0b9cd0a | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-06 | 170 | 25 | 4 | 830646815410c47e9bca8c9bae75dfc45c9c9b33 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.07e-06 | 182 | 25 | 4 | 52eac2f892ea7f26731e0b21c578fd2665a1657a | |
| ToppCell | control-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.95e-06 | 194 | 25 | 4 | 267e213e8efe53aadfe553a2ca010a0e3b4b8939 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-06 | 194 | 25 | 4 | 01eab9f799a0bf4af1f2bffedaa1d926d98abe0f | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.95e-06 | 194 | 25 | 4 | f51760caee571307851c78897789f6e43bac44ae | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 4.11e-06 | 196 | 25 | 4 | 2bc67c2346dfb7732e2e6bb273f3da1c5ee6cf0a | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.28e-06 | 198 | 25 | 4 | 2aa4ce3df4b60618f678aa740e57b4b42707d792 | |
| ToppCell | (0)_Myeloid-(00)_Monocyte|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 4.28e-06 | 198 | 25 | 4 | 9c17589ef0f6583c4c106c06936877fd74c258ce | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.37e-06 | 199 | 25 | 4 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.37e-06 | 199 | 25 | 4 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.78e-05 | 117 | 25 | 3 | 3d98d77b4725d684e7496059e8b0ffffbe40301d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.78e-05 | 117 | 25 | 3 | 089793a950e8593b4acc1ba6a5e5474682f5fda6 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.72e-05 | 126 | 25 | 3 | ec32bfd6cd93fbe02f7577893c82b04d209a52e7 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.29e-05 | 131 | 25 | 3 | fdec4e31ffeb02615ccb7097758a8218dd1f8c1c | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.66e-05 | 134 | 25 | 3 | 7b237690a3765d974f6f813ef2d01154bc23b9d6 | |
| ToppCell | COVID-19_Mild-Myeloid_G-Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 5.79e-05 | 135 | 25 | 3 | e9eb2bebb6d19c439c83f46c12ca0d676db69de8 | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 6.73e-05 | 142 | 25 | 3 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.73e-05 | 142 | 25 | 3 | bf3537bec0eca9f90c00df9ba840c371f1c9856e | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.87e-05 | 143 | 25 | 3 | 974260c25dad599eea83a33e83117f7307b92a42 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 144 | 25 | 3 | c0c5f254a960ba5e5f1354599d54e77360e6c2ac | |
| ToppCell | PND14-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 144 | 25 | 3 | 1efa434e577d1f87e02df01667782f414d63bd60 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-05 | 145 | 25 | 3 | 88e463d5396a8fea2b7b1ecf3c9b144e16b35234 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.16e-05 | 145 | 25 | 3 | 911fee7f27694393e348d94470a1a4e890038902 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.92e-05 | 150 | 25 | 3 | 34774b015adecc2be56a471fda8994e89a6ad93e | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(Cd4+_Tnaive-Tcm)|Lymphoid / shred on cell class and cell subclass (v4) | 8.39e-05 | 153 | 25 | 3 | ffb8ac88513e83d3ba01574e60beb5476154372b | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Platelets-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-05 | 158 | 25 | 3 | f2c39b2eff8f2728a9d482d88e0d04984306a3fd | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.23e-05 | 158 | 25 | 3 | fa9797a23254070c569fabe8a314b3e8b3ae9ebd | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 162 | 25 | 3 | dddf7a3901ae59e3494d8a6740db0fa15cc96d47 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 162 | 25 | 3 | 2a4e09545e9874519f0f56e81065104987d81cd6 | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 164 | 25 | 3 | d57faa4fce1f1e9a92aaf5cb920af99323252e4b | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 164 | 25 | 3 | 45a6d809d92fd4eee906da3c812282bacffc9f2f | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 164 | 25 | 3 | aa4358311fc767c292897e3328309d1bcda392d4 | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.07e-04 | 166 | 25 | 3 | 07b498eb341abec02a3ccaae320bdbb5cd6883c5 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.07e-04 | 166 | 25 | 3 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-04 | 166 | 25 | 3 | fab4da2537904ad114218f720e18a600f14a00a1 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 170 | 25 | 3 | 90f7640f04672c800cb28aea50004b1bb0565e8a | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 171 | 25 | 3 | f08402d0f42822c35673522043b652f8fb68d2f6 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.19e-04 | 172 | 25 | 3 | 25bf2551d698237bfd912c2ff067b1600dfb19ca | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.19e-04 | 172 | 25 | 3 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | severe_COVID-19-Neutrophil|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.19e-04 | 172 | 25 | 3 | 8f4bcb9b2bbf8b4333f673d8ad6bb88dfda4792a | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 172 | 25 | 3 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN4|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 172 | 25 | 3 | d098e8a9c7666354803225cf2650faad436bab66 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.21e-04 | 173 | 25 | 3 | 46dbc51270cc80d6e0b7118c53cec8516b1bb508 | |
| ToppCell | 3'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.25e-04 | 175 | 25 | 3 | cd42020fe57afeaadfbd3ef6d7375e66d71e9669 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 175 | 25 | 3 | f7547eade69aa1d012db963adf59f36a309beae6 | |
| ToppCell | 18-Distal-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.25e-04 | 175 | 25 | 3 | cc476b4244442418b8f21721a82a36209b556b36 | |
| ToppCell | 18-Distal-RBC-RBC|Distal / Age, Tissue, Lineage and Cell class | 1.25e-04 | 175 | 25 | 3 | 7130b816e0c02309c161d8e9ad7cb4bc2469e251 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 177 | 25 | 3 | 0d6167c6a11c7dec0717ae7c8b4c45341585804f | |
| ToppCell | normal_Lung-Myeloid_cells-CD163+CD14+_DCs|normal_Lung / Location, Cell class and cell subclass | 1.31e-04 | 178 | 25 | 3 | b6dacaad09bf4384d0d4c926fbf769e74a8ec9a9 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 178 | 25 | 3 | 65508833f9f7fb03d54b62cec9a1337a06b65031 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.31e-04 | 178 | 25 | 3 | ec6364432d37a32f5152d36d89f5e96dddb72a9d | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.31e-04 | 178 | 25 | 3 | a1f2c134bb7596f678fb4cc11405c374d926ea0f | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 181 | 25 | 3 | e2481291c236105774c53883e6f20da11941df9b | |
| ToppCell | PCW_05-06-Immune_Lymphocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 181 | 25 | 3 | bd99c5849bb4979c891898312cb9f602c6831b23 | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.38e-04 | 181 | 25 | 3 | f737f2b1f35747b81fdd8996e289bde5c290af61 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 181 | 25 | 3 | 782716b8b1d447d2bbe09a693fa5ed7ebeac0efb | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.40e-04 | 182 | 25 | 3 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-04 | 182 | 25 | 3 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.40e-04 | 182 | 25 | 3 | 01ae44b465e509b0aa75ccf61bd9bc0a89d6758c | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 182 | 25 | 3 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.40e-04 | 182 | 25 | 3 | b427e43ee523a3ea9eca3207f3d82042f10f022a | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.40e-04 | 182 | 25 | 3 | 1aea96ee211f7b9caef7fd385233f51be6021a73 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 182 | 25 | 3 | c0f63cfc67d61c0877b7acb2946dfb35aae8a8f5 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.40e-04 | 182 | 25 | 3 | 4cb182ef39be2044a6ad7266f332d4177591e550 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-04 | 182 | 25 | 3 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.43e-04 | 183 | 25 | 3 | ffa7f2b2929ea4bd53f3f1ae23bd27f8bb4aac47 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 183 | 25 | 3 | cff3197e9ff401362501db2317c86adc6d24b595 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 183 | 25 | 3 | f803dd2881ceaed6327e21a1a51bc3d3ccf4b5f8 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-CD4+_T_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.43e-04 | 183 | 25 | 3 | 7717fce227b4e02ed41baad8ae7dd2e22bd7c13e | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-04 | 183 | 25 | 3 | 4bd6883daf2dbe8c1b49b776b48d41f9890d1cb4 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.43e-04 | 183 | 25 | 3 | 41ae679e7332fcafa9101e62a4a910ebae63e87c | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Neutrophil|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-04 | 184 | 25 | 3 | 4c7d05f1a4556b13cedbaaf88d67ac32d09b109b | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 184 | 25 | 3 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | PCW_05-06-Immune_Lymphocytic-Immune_Lymphocytic_B-im_lymphoid_progenitor_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.47e-04 | 185 | 25 | 3 | 5ec2c3ae5c477645241e8eaf19d222562e1f7ed6 | |
| ToppCell | droplet-Thymus|droplet / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 185 | 25 | 3 | 83a78d17ad59503a694c1250082c4d8ae74d63e1 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 185 | 25 | 3 | 39f2b7a35253968f6d744c10ece1478a05cf24da | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-Neutrophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.47e-04 | 185 | 25 | 3 | 2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed | |
| ToppCell | LPS-IL1RA-Myeloid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-04 | 185 | 25 | 3 | 9b5fd87ea9d05e051ff1251578ecfbe5e8652853 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 186 | 25 | 3 | be50f5c7f32b3126442ebff1e7d38aa78b6e4e71 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Cycling_DC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.50e-04 | 186 | 25 | 3 | de1f0bc5dbf6dc0e716f5ebbf2bbcfe249811c54 | |
| ToppCell | LPS-antiTNF-Myeloid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 186 | 25 | 3 | 839c6da5244f469461b2e5563e36162b2911cd01 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-04 | 187 | 25 | 3 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-04 | 188 | 25 | 3 | e0184d9f6687d7ecb8fc461294ff7208f49c437c | |
| ToppCell | PCW_05-06-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 188 | 25 | 3 | f4d11d06be46f13adbf36d94bc2bdcd14d0bfa75 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-Promonocyte-like|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 188 | 25 | 3 | 2ae945d96a011f246d04a42bcd6ef443232b03f4 | |
| ToppCell | PCW_10-12-Hematologic_ErythroMegGranulo|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.54e-04 | 188 | 25 | 3 | adf9011ba8e3c6418fb68bf5c44b2e3b0ec7dafe | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 189 | 25 | 3 | 8419d62e6991851bdc6ad861f5c9086ff808b222 | |
| ToppCell | COVID-19_Severe-Myeloid_G-Neutrophil|COVID-19_Severe / Disease group, lineage and cell class | 1.57e-04 | 189 | 25 | 3 | a62f4c445ede00d15b74bee65f4e4fb54cfd4d32 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.57e-04 | 189 | 25 | 3 | f6b2b4824505f0119a017fdb73c55418fb651645 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.57e-04 | 189 | 25 | 3 | db8e314ce95c32542bb4015a77032a33211fea0b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-MPO+_mono-neutrophil|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-04 | 190 | 25 | 3 | bee9c9d0fc9cfba0a67dacc4569307cb326d489b | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-04 | 190 | 25 | 3 | 57800d807785b9d539b47945a0a74631f5e88a06 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Classical_monocytes|Lung / Manually curated celltypes from each tissue | 1.59e-04 | 190 | 25 | 3 | a2574f0876ebae3a1d2a39a79cc6cadac8ee1688 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.59e-04 | 190 | 25 | 3 | cb62ece5929896dfba30a4f563c6ba5a5712b71e | |
| ToppCell | PCW_05-06-Hematologic_ErythroMegGranulo-Hem_Granulocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | 8e254fc77dd1d2d2a4ce0700af3c37829ca089bf | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | 773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d | |
| ToppCell | COVID-19_Severe-Myeloid_G|COVID-19_Severe / Disease group, lineage and cell class | 1.59e-04 | 190 | 25 | 3 | 8a81cb90273c361e9fdfaa0a31806da253fa1388 | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.59e-04 | 190 | 25 | 3 | 902afe2121593ae08d083c2cea2d1ba9f848574a | |
| Disease | Influenza | 7.53e-04 | 52 | 23 | 2 | C0021400 | |
| Disease | Fatty Liver | 2.14e-03 | 88 | 23 | 2 | C0015695 | |
| Disease | Steatohepatitis | 2.14e-03 | 88 | 23 | 2 | C2711227 | |
| Disease | Adenocarcinoma | 3.67e-03 | 116 | 23 | 2 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 3.67e-03 | 116 | 23 | 2 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.67e-03 | 116 | 23 | 2 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.67e-03 | 116 | 23 | 2 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.67e-03 | 116 | 23 | 2 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.67e-03 | 116 | 23 | 2 | C0205641 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GQRFKTRKRDEKEKF | 11 | Q9Y6E2 | |
| ERFKGKEETEGFKID | 296 | Q6P1J9 | |
| GVKRFREFLKKEFSE | 51 | O43665 | |
| TRLEDAKKDFEKKFR | 116 | Q9Y6F1 | |
| GLEKKFRLDIFKDFQ | 961 | Q6PKG0 | |
| FGRVKFERKGEELKA | 1241 | Q8IY21 | |
| AEDAKDFFKRKIDFL | 96 | Q99471 | |
| KFGKDVKIDLFEREE | 56 | Q9UHG3 | |
| KRKFGFEENKIDRTF | 181 | Q9BWT6 | |
| FFRRRKTDEEDDKEK | 931 | Q9H792 | |
| EEKDFRKKFKYDGEI | 691 | O15117 | |
| DEKKKFLFFLTGRDR | 941 | Q8IVU3 | |
| KKAEKVDFRRLGEEF | 131 | Q5JPI3 | |
| GDFFRKSKEKIGKEF | 136 | P49913 | |
| EKIAETDFEKRDFRK | 146 | Q99615 | |
| KGVFERDFFKTRSKE | 761 | Q8N7U6 | |
| DRFIEDGKKKTTFFK | 416 | O75881 | |
| KEFVADIFRRAKEAK | 321 | Q66K64 | |
| KIRFFFEKGVFDEKG | 76 | Q5SRE7 | |
| KAEREFRKKFKFEGE | 571 | Q96QH2 | |
| FKEAEKSFRRDKELG | 806 | Q9P2K2 | |
| AAKLFDEEGRKKFFT | 466 | Q6ZU65 | |
| EKFKDREKAQDLFKF | 2776 | Q15413 | |
| IKRDFGSFDKFKEKL | 121 | P04179 | |
| TEFAGDKFKEEKVFE | 211 | O43615 |